Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Folic acid supplementation and risk of colorectal neoplasia during long-term follow-up of a randomized clinical trial.

Passarelli MN, Barry EL, Rees JR, Mott LA, Zhang D, Ahnen DJ, Bresalier RS, Haile RW, McKeown-Eyssen G, Snover DC, Cole BF, Baron JA.

Am J Clin Nutr. 2019 Oct 1;110(4):903-911. doi: 10.1093/ajcn/nqz160.

PMID:
31401653
2.

Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas.

Passarelli MN, Barry EL, Zhang D, Gangar P, Rees JR, Bresalier RS, McKeown-Eyssen G, Karagas MR, Baron JA.

Br J Dermatol. 2018 Aug;179(2):337-344. doi: 10.1111/bjd.16571. Epub 2018 Jun 19.

3.

Unmetabolized Folic Acid, Tetrahydrofolate, and Colorectal Adenoma Risk.

Rees JR, Morris CB, Peacock JL, Ueland PM, Barry EL, McKeown-Eyssen GE, Figueiredo JC, Snover DC, Baron JA.

Cancer Prev Res (Phila). 2017 Aug;10(8):451-458. doi: 10.1158/1940-6207.CAPR-16-0278. Epub 2017 Jun 9.

4.

Cross-sectional associations between dietary intake and carotid intima media thickness in type 2 diabetes: baseline data from a randomised trial.

Chiavaroli L, Mirrahimi A, Ireland C, Mitchell S, Sahye-Pudaruth S, Coveney J, Olowoyeye O, Patel D, de Souza RJ, Augustin LS, Bashyam B, Pichika SC, Blanco Mejia S, Nishi SK, Leiter LA, Josse RG, McKeown-Eyssen GE, Moody AR, Kendall CW, Sievenpiper JL, Jenkins DJ.

BMJ Open. 2017 Mar 22;7(3):e015026. doi: 10.1136/bmjopen-2016-015026.

5.

Plasma lipoxin A4 and resolvin D1 are not associated with reduced adenoma risk in a randomized trial of aspirin to prevent colon adenomas.

Fedirko V, McKeown-Eyssen G, Serhan CN, Barry EL, Sandler RS, Figueiredo JC, Ahnen DJ, Bresalier RS, Robertson DJ, Anderson CW, Baron JA.

Mol Carcinog. 2017 Aug;56(8):1977-1983. doi: 10.1002/mc.22629. Epub 2017 Mar 6.

6.

Low-glycaemic index diet to improve glycaemic control and cardiovascular disease in type 2 diabetes: design and methods for a randomised, controlled, clinical trial.

Chiavaroli L, Mirrahimi A, Ireland C, Mitchell S, Sahye-Pudaruth S, Coveney J, Olowoyeye O, Maraj T, Patel D, de Souza RJ, Augustin LS, Bashyam B, Blanco Mejia S, Nishi SK, Leiter LA, Josse RG, McKeown-Eyssen G, Moody AR, Berger AR, Kendall CW, Sievenpiper JL, Jenkins DJ.

BMJ Open. 2016 Jul 7;6(7):e012220. doi: 10.1136/bmjopen-2016-012220.

7.

Serum Endotoxins and Flagellin and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort.

Kong SY, Tran HQ, Gewirtz AT, McKeown-Eyssen G, Fedirko V, Romieu I, Tjønneland A, Olsen A, Overvad K, Boutron-Ruault MC, Bastide N, Affret A, Kühn T, Kaaks R, Boeing H, Aleksandrova K, Trichopoulou A, Kritikou M, Vasilopoulou E, Palli D, Krogh V, Mattiello A, Tumino R, Naccarati A, Bueno-de-Mesquita HB, Peeters PH, Weiderpass E, Quirós JR, Sala N, Sánchez MJ, Castaño JM, Barricarte A, Dorronsoro M, Werner M, Wareham NJ, Khaw KT, Bradbury KE, Freisling H, Stavropoulou F, Ferrari P, Gunter MJ, Cross AJ, Riboli E, Bruce WR, Jenab M.

Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):291-301. doi: 10.1158/1055-9965.EPI-15-0798. Epub 2016 Jan 11.

8.

The Association between Glyceraldehyde-Derived Advanced Glycation End-Products and Colorectal Cancer Risk.

Kong SY, Takeuchi M, Hyogo H, McKeown-Eyssen G, Yamagishi S, Chayama K, O'Brien PJ, Ferrari P, Overvad K, Olsen A, Tjønneland A, Boutron-Ruault MC, Bastide N, Carbonnel F, Kühn T, Kaaks R, Boeing H, Aleksandrova K, Trichopoulou A, Lagiou P, Vasilopoulou E, Masala G, Pala V, Santucci De Magistris M, Tumino R, Naccarati A, Bueno-de-Mesquita HB, Peeters PH, Weiderpass E, Quirós JR, Jakszyn P, Sánchez MJ, Dorronsoro M, Gavrila D, Ardanaz E, Rutegård M, Nyström H, Wareham NJ, Khaw KT, Bradbury KE, Romieu I, Freisling H, Stavropoulou F, Gunter MJ, Cross AJ, Riboli E, Jenab M, Bruce WR.

Cancer Epidemiol Biomarkers Prev. 2015 Dec;24(12):1855-63. doi: 10.1158/1055-9965.EPI-15-0422. Epub 2015 Sep 24.

9.

Smoking-associated risks of conventional adenomas and serrated polyps in the colorectum.

Figueiredo JC, Crockett SD, Snover DC, Morris CB, McKeown-Eyssen G, Sandler RS, Ahnen DJ, Robertson DJ, Burke CA, Bresalier RS, Church JM, Church TR, Baron JA.

Cancer Causes Control. 2015 Mar;26(3):377-86. doi: 10.1007/s10552-014-0513-0. Epub 2014 Dec 24.

10.

Case-control and prospective studies of dietary α-linolenic acid intake and prostate cancer risk: a meta-analysis.

Carleton AJ, Sievenpiper JL, de Souza R, McKeown-Eyssen G, Jenkins DJ.

BMJ Open. 2013 May 14;3(5). pii: e002280. doi: 10.1136/bmjopen-2012-002280.

11.

CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment.

Barry EL, Poole EM, Baron JA, Makar KW, Mott LA, Sandler RS, Ahnen DJ, Bresalier RS, McKeown-Eyssen GE, Ulrich CM.

Cancer Causes Control. 2013 Jan;24(1):47-54. doi: 10.1007/s10552-012-0088-6. Epub 2012 Oct 19.

12.

Bias in the case-only design applied to studies of gene-environment and gene-gene interaction: a systematic review and meta-analysis.

Dennis J, Hawken S, Krewski D, Birkett N, Gheorghe M, Frei J, McKeown-Eyssen G, Little J.

Int J Epidemiol. 2011 Oct;40(5):1329-41. doi: 10.1093/ije/dyr088. Epub 2011 Jul 4. Review.

PMID:
21729879
13.

Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa.

Wallace K, Grau MV, Levine AJ, Shen L, Hamdan R, Chen X, Gui J, Haile RW, Barry EL, Ahnen D, McKeown-Eyssen G, Baron JA, Issa JP.

Cancer Prev Res (Phila). 2010 Dec;3(12):1552-64. doi: 10.1158/1940-6207.CAPR-10-0047.

14.

Use of folic acid-containing supplements after a diagnosis of colorectal cancer in the Colon Cancer Family Registry.

Holmes RS, Zheng Y, Baron JA, Li L, McKeown-Eyssen G, Newcomb PA, Stern MC, Haile RW, Grady WM, Potter JD, Le Marchand L, Campbell PT, Figueiredo JC, Limburg PJ, Jenkins MA, Hopper JL, Ulrich CM; Colon Cancer Family Registry.

Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):2023-34. doi: 10.1158/1055-9965.EPI-09-1097.

15.

Bioavailability of vitamins E and C: does Helicobacter pylori infection play a role?

Naja F, Kreiger N, McKeown Eyssen G, Allard J.

Ann Nutr Metab. 2010;56(4):253-9. doi: 10.1159/000281819. Epub 2010 Apr 14.

PMID:
20389061
16.

Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas.

Ho GY, Xue X, Cushman M, McKeown-Eyssen G, Sandler RS, Ahnen DJ, Barry EL, Saibil F, Bresalier RS, Rohan TE, Baron JA.

J Natl Cancer Inst. 2009 Dec 2;101(23):1650-4. doi: 10.1093/jnci/djp346. Epub 2009 Oct 12.

17.

Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.

Barry EL, Sansbury LB, Grau MV, Ali IU, Tsang S, Munroe DJ, Ahnen DJ, Sandler RS, Saibil F, Gui J, Bresalier RS, McKeown-Eyssen GE, Burke C, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2726-33. doi: 10.1158/1055-9965.EPI-09-0363. Epub 2009 Sep 15.

18.

Penetrance of colorectal cancer among MLH1/MSH2 carriers participating in the colorectal cancer familial registry in Ontario.

Choi YH, Cotterchio M, McKeown-Eyssen G, Neerav M, Bapat B, Boyd K, Gallinger S, McLaughlin J, Aronson M, Briollais L.

Hered Cancer Clin Pract. 2009 Aug 23;7(1):14. doi: 10.1186/1897-4287-7-14.

19.

The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum.

Wallace K, Grau MV, Ahnen D, Snover DC, Robertson DJ, Mahnke D, Gui J, Barry EL, Summers RW, McKeown-Eyssen G, Haile RW, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2310-7. doi: 10.1158/1055-9965.EPI-09-0211.

20.

Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors.

Figueiredo JC, Grau MV, Wallace K, Levine AJ, Shen L, Hamdan R, Chen X, Bresalier RS, McKeown-Eyssen G, Haile RW, Baron JA, Issa JP.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1041-9. doi: 10.1158/1055-9965.EPI-08-0926. Epub 2009 Mar 31.

21.

Folic acid and risk of prostate cancer: results from a randomized clinical trial.

Figueiredo JC, Grau MV, Haile RW, Sandler RS, Summers RW, Bresalier RS, Burke CA, McKeown-Eyssen GE, Baron JA.

J Natl Cancer Inst. 2009 Mar 18;101(6):432-5. doi: 10.1093/jnci/djp019. Epub 2009 Mar 10.

22.

Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.

Grau MV, Sandler RS, McKeown-Eyssen G, Bresalier RS, Haile RW, Barry EL, Ahnen DJ, Gui J, Summers RW, Baron JA.

J Natl Cancer Inst. 2009 Feb 18;101(4):267-76. doi: 10.1093/jnci/djn484. Epub 2009 Feb 10.

23.

Association between body mass index and colorectal neoplasia at follow-up colonoscopy: a pooling study.

Jacobs ET, Ahnen DJ, Ashbeck EL, Baron JA, Greenberg ER, Lance P, Lieberman DA, McKeown-Eyssen G, Schatzkin A, Thompson PA, Martínez ME.

Am J Epidemiol. 2009 Mar 15;169(6):657-66. doi: 10.1093/aje/kwn401. Epub 2009 Jan 15.

24.

Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial.

Jenkins DJ, Kendall CW, McKeown-Eyssen G, Josse RG, Silverberg J, Booth GL, Vidgen E, Josse AR, Nguyen TH, Corrigan S, Banach MS, Ares S, Mitchell S, Emam A, Augustin LS, Parker TL, Leiter LA.

JAMA. 2008 Dec 17;300(23):2742-53. doi: 10.1001/jama.2008.808.

PMID:
19088352
25.

Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels.

Figueiredo JC, Levine AJ, Grau MV, Barry EL, Ueland PM, Ahnen DJ, Byers T, Bresalier RS, Summers RW, Bond J, McKeown-Eyssen GE, Sandler RS, Haile RW, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2625-31. doi: 10.1158/1055-9965.EPI-08-0382.

26.

Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.

Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, McKeown-Eyssen G, Summers RW, Rothstein RI, Burke CA, Snover DC, Church TR, Allen JI, Robertson DJ, Beck GJ, Bond JH, Byers T, Mandel JS, Mott LA, Pearson LH, Barry EL, Rees JR, Marcon N, Saibil F, Ueland PM, Greenberg ER; Polyp Prevention Study Group.

JAMA. 2007 Jun 6;297(21):2351-9.

PMID:
17551129
27.
28.

Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States).

Kim S, Baron JA, Mott LA, Burke CA, Church TR, McKeown-Eyssen GE, Cole BF, Haile RW, Sandler RS.

Cancer Causes Control. 2006 Dec;17(10):1299-304.

PMID:
17111262
29.

University of Toronto case-control study of multiple chemical sensitivity-3: intra-erythrocytic mineral levels.

Baines CJ, McKeown-Eyssen GE, Riley N, Marshall L, Jazmaji V.

Occup Med (Lond). 2007 Mar;57(2):137-40. Epub 2006 Oct 17.

PMID:
17046989
30.

Methodologic issues for the study of obesity.

McKeown-Eyssen G.

Epidemiology. 2006 Mar;17(2):134-5. No abstract available.

PMID:
16477251
31.

Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo.

Tran TT, Naigamwalla D, Oprescu AI, Lam L, McKeown-Eyssen G, Bruce WR, Giacca A.

Endocrinology. 2006 Apr;147(4):1830-7. Epub 2006 Jan 12.

PMID:
16410309
32.

Colorectal cancer in patients under close colonoscopic surveillance.

Robertson DJ, Greenberg ER, Beach M, Sandler RS, Ahnen D, Haile RW, Burke CA, Snover DC, Bresalier RS, McKeown-Eyssen G, Mandel JS, Bond JH, Van Stolk RU, Summers RW, Rothstein R, Church TR, Cole BF, Byers T, Mott L, Baron JA.

Gastroenterology. 2005 Jul;129(1):34-41.

PMID:
16012932
33.

Case-control study of multiple chemical sensitivity, comparing haematology, biochemistry, vitamins and serum volatile organic compound measures.

Baines CJ, McKeown-Eyssen GE, Riley N, Cole DE, Marshall L, Loescher B, Jazmaji V.

Occup Med (Lond). 2004 Sep;54(6):408-18. Epub 2004 Sep 3.

PMID:
15347780
34.

Case-control study of genotypes in multiple chemical sensitivity: CYP2D6, NAT1, NAT2, PON1, PON2 and MTHFR.

McKeown-Eyssen G, Baines C, Cole DE, Riley N, Tyndale RF, Marshall L, Jazmaji V.

Int J Epidemiol. 2004 Oct;33(5):971-8. Epub 2004 Jul 15.

PMID:
15256524
35.
36.

A randomized trial of aspirin to prevent colorectal adenomas.

Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, McKeown-Eyssen G, Summers RW, Rothstein R, Burke CA, Snover DC, Church TR, Allen JI, Beach M, Beck GJ, Bond JH, Byers T, Greenberg ER, Mandel JS, Marcon N, Mott LA, Pearson L, Saibil F, van Stolk RU.

N Engl J Med. 2003 Mar 6;348(10):891-9.

37.

Direct measure of insulin sensitivity with the hyperinsulinemic-euglycemic clamp and surrogate measures of insulin sensitivity with the oral glucose tolerance test: correlations with aberrant crypt foci promotion in rats.

Tran TT, Gupta N, Goh T, Naigamwalla D, Chia MC, Koohestani N, Mehrotra S, McKeown-Eyssen G, Giacca A, Bruce WR.

Cancer Epidemiol Biomarkers Prev. 2003 Jan;12(1):47-56.

38.

Familial aggregation of diabetes and hypertension in a case-control study of colorectal neoplasia.

Brauer PM, McKeown-Eyssen GE, Jazmaji V, Logan AG, Andrews DF, Jenkins D, Marcon N, Saibil F, Cohen L, Stern H, Baron D, Greenberg G, Diamandis E, Kakis G, Singer W, Steiner G.

Am J Epidemiol. 2002 Oct 15;156(8):702-13.

PMID:
12370158
39.

Association of parity with risk of type 2 diabetes and related metabolic disorders.

Hanley AJ, McKeown-Eyssen G, Harris SB, Hegele RA, Wolever TM, Kwan J, Zinman B.

Diabetes Care. 2002 Apr;25(4):690-5.

PMID:
11919126
40.

Cross-sectional and prospective associations between abdominal adiposity and proinsulin concentration.

Hanley AJ, McKeown-Eyssen G, Harris SB, Hegele RA, Wolever TM, Kwan J, Zinman B.

J Clin Endocrinol Metab. 2002 Jan;87(1):77-83.

PMID:
11788626
41.

Multiple chemical sensitivity: discriminant validity of case definitions.

McKeown-Eyssen GE, Baines CJ, Marshall LM, Jazmaji V, Sokoloff ER.

Arch Environ Health. 2001 Sep-Oct;56(5):406-12.

PMID:
11777021
42.

Cross-sectional and prospective associations between proinsulin and cardiovascular disease risk factors in a population experiencing rapid cultural transition.

Hanley AJ, McKeown-Eyssen G, Harris SB, Hegele RA, Wolever TM, Kwan J, Connelly PW, Zinman B.

Diabetes Care. 2001 Jul;24(7):1240-7. Erratum in: Diabetes Care 2001 Oct;24(10):1851.

PMID:
11423509
43.

Ontario familial colon cancer registry: methods and first-year response rates.

Cotterchio M, McKeown-Eyssen G, Sutherland H, Buchan G, Aronson M, Easson AM, Macey J, Holowaty E, Gallinger S.

Chronic Dis Can. 2000;21(2):81-6.

PMID:
11007659
44.

Reproducibility of the University of Toronto self-administered questionnaire used to assess environmental sensitivity.

McKeown-Eyssen GE, Sokoloff ER, Jazmaji V, Marshall LM, Baines CJ.

Am J Epidemiol. 2000 Jun 15;151(12):1216-22.

PMID:
10905534
45.

Insulin and related factors in premenopausal breast cancer risk.

Del Giudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D, Goodwin PJ.

Breast Cancer Res Treat. 1998 Jan;47(2):111-20.

PMID:
9497099
46.

Impact of menstrual phase on false-negative mammograms in the Canadian National Breast Screening Study.

Baines CJ, Vidmar M, McKeown-Eyssen G, Tibshirani R.

Cancer. 1997 Aug 15;80(4):720-4.

PMID:
9264355
47.

Research initiatives at the University of Toronto Environmental Hypersensitivity Research Unit.

McKeown-Eyssen G, Marshall L, Baines C, Rodin G.

Regul Toxicol Pharmacol. 1996 Aug;24(1 Pt 2):S126-8.

PMID:
8921567
48.

Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk?

McKeown-Eyssen G.

Cancer Epidemiol Biomarkers Prev. 1994 Dec;3(8):687-95. Review.

49.

A randomized trial of a low fat high fibre diet in the recurrence of colorectal polyps. Toronto Polyp Prevention Group.

McKeown-Eyssen GE, Bright-See E, Bruce WR, Jazmaji V, Cohen LB, Pappas SC, Saibil FG.

J Clin Epidemiol. 1994 May;47(5):525-36. Erratum in: J Clin Epidemiol 1995 Feb;48(2):i.

PMID:
7730878
50.

High-molecular-weight cytokeratin and cytokeratin-19 in the diagnosis of thyroid tumors.

Raphael SJ, McKeown-Eyssen G, Asa SL.

Mod Pathol. 1994 Apr;7(3):295-300.

PMID:
7520169

Supplemental Content

Loading ...
Support Center